Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:30 PM
Ignite Modification Date: 2025-12-25 @ 1:04 PM
NCT ID: NCT02963259
Description: None
Frequency Threshold: 0
Time Frame: 12 months
Study: NCT02963259
Study Brief: IPG Replacement Study (PREFERENCE-H)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
SJM Infinity™ DBS IPG or a SJM Brio™ DBS IPG System Subjects will be implanted with SJM Infinity™ DBS IPG or a SJM Brio™ DBS IPG system SJM Infinity™ DBS IPG or SJM Brio™ DBS IPG system: Implanted Medtronic® IPG will be explanted and replaced by a SJM Infinity™ DBS IPG or a SJM Brio™ DBS IPG system 1 None 1 17 1 17 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Lung Cancer SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA 11.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
High Impedance in Contact SYSTEMATIC_ASSESSMENT Product Issues MedDRA 11.0 View
Worsening of Motor/Parkinson's Disease Symptoms - Akinesia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 11.0 View